Keith Rosenbloom Sells 556,580 Shares of American Vanguard (NYSE:AVD) Stock

American Vanguard Corporation (NYSE:AVD) Director Keith Rosenbloom sold 556,580 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $2.20, for a total value of $1,224,476.00. Following the completion of the sale, the director owned 15,201 shares of the company’s stock, valued at approximately $33,442.20. This trade represents a 97.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

American Vanguard Price Performance

NYSE:AVD opened at $2.33 on Friday. The business’s 50-day moving average price is $2.57 and its 200 day moving average price is $3.11. The firm has a market cap of $68.74 million, a P/E ratio of -1.23 and a beta of 1.43. American Vanguard Corporation has a 52-week low of $2.03 and a 52-week high of $5.92. The company has a quick ratio of 1.40, a current ratio of 2.47 and a debt-to-equity ratio of 1.46.

American Vanguard (NYSE:AVD) last issued its quarterly earnings results on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.The business had revenue of $116.75 million during the quarter, compared to the consensus estimate of $135.00 million.

Analyst Upgrades and Downgrades

Several research firms recently commented on AVD. Weiss Ratings reissued a “sell (e+)” rating on shares of American Vanguard in a research note on Thursday, August 13th. Wall Street Zen lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, American Vanguard currently has a consensus rating of “Sell”.

Hedge Funds Weigh In On American Vanguard

Hedge funds and other institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. increased its stake in American Vanguard by 15.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 22,456 shares of the basic materials company’s stock worth $129,000 after purchasing an additional 2,921 shares in the last quarter. Barclays PLC lifted its stake in American Vanguard by 3.6% during the fourth quarter. Barclays PLC now owns 126,269 shares of the basic materials company’s stock valued at $482,000 after buying an additional 4,391 shares in the last quarter. Strs Ohio purchased a new stake in American Vanguard during the first quarter valued at about $28,000. Gamco Investors INC. ET AL boosted its holdings in shares of American Vanguard by 13.3% in the first quarter. Gamco Investors INC. ET AL now owns 68,000 shares of the basic materials company’s stock worth $169,000 after buying an additional 8,000 shares during the period. Finally, Wells Fargo & Company MN boosted its holdings in shares of American Vanguard by 46.2% in the fourth quarter. Wells Fargo & Company MN now owns 28,650 shares of the basic materials company’s stock worth $109,000 after buying an additional 9,055 shares during the period. Institutional investors and hedge funds own 79.00% of the company’s stock.

About American Vanguard

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.